Literature DB >> 29550194

Morphological characterization of a plant-made virus-like particle vaccine bearing influenza virus hemagglutinins by electron microscopy.

Brianne J Lindsay1, Michal M Bonar1, Ian N Costas-Cancelas1, Kristin Hunt2, Alexander I Makarkov3, Sabrina Chierzi3, Connie M Krawczyk2, Nathalie Landry4, Brian J Ward3, Isabelle Rouiller5.   

Abstract

Plant-made virus-like particle (VLP) vaccines that display wild-type influenza hemagglutinin (HA) are rapidly advancing through clinical trials. Produced by transient transfection of Nicotiana benthamiana, these novel vaccines are unusually immunogenic, eliciting both humoral and cellular responses. Here, we directly visualized VLPs bearing either HA trimers derived from strains A/California/7/2009 or A/Indonesia/5/05 using cryo-electron microscopy and determined the 3D organization of the VLPs using cryo-electron tomography. More than 99.9% of the HA trimers in the vaccine preparations were found on discoid and ovoid-shaped particles. The discoid-shaped VLPs presented HA trimers on their outer diameter. The ovoid-shaped VLPs contained HA trimers evenly distributed at their surface. The VLPs were stable for 12 months at 4 °C. Early interactions of the VLPs with mouse dendritic and human monocytoid (U-937) cells were visualized by electron microscopy after resin-embedding and sectioning. The VLP particles were observed bound to plasma membranes as well as inside vesicles. Mouse dendritic cells exposed to VLPs displayed classic morphological changes associated with activation including the extensive formation of dendrites. Our findings demonstrate that plant-made VLPs bearing influenza HA trimers are morphologically stable over time and raise the possibility that these VLPs may interact with and activate antigen-presenting cells in a manner similar to the intact virus.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Antigen presenting cells; Cellular activation; Cryo-electron microscopy; Hemagglutinin; Phase plate tomography; Plant-made virus-like particle

Mesh:

Substances:

Year:  2018        PMID: 29550194     DOI: 10.1016/j.vaccine.2018.02.106

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  17 in total

Review 1.  Plant-Derived Human Vaccines: Recent Developments.

Authors:  Jennifer Stander; Sandiswa Mbewana; Ann E Meyers
Journal:  BioDrugs       Date:  2022-07-12       Impact factor: 7.744

2.  Correlative imaging using super-resolution fluorescence microscopy and soft X-ray tomography at cryogenic temperatures provides a new way to assess virosome solutions for vaccine development.

Authors:  Chidinma A Okolo; Archana Jadhav; Patrick Phillips; Maud Dumoux; Amanda A McMurray; Vishwas D Joshi; Claire Pizzey; Maria Harkiolaki
Journal:  J Microsc       Date:  2021-09-03       Impact factor: 1.952

Review 3.  Characterization of Hemagglutinin Antigens on Influenza Virus and within Vaccines Using Electron Microscopy.

Authors:  John R Gallagher; Dustin M McCraw; Udana Torian; Neetu M Gulati; Mallory L Myers; Michael T Conlon; Audray K Harris
Journal:  Vaccines (Basel)       Date:  2018-05-25

4.  Immunogenicity and safety of a quadrivalent plant-derived virus like particle influenza vaccine candidate-Two randomized Phase II clinical trials in 18 to 49 and ≥50 years old adults.

Authors:  Stéphane Pillet; Julie Couillard; Sonia Trépanier; Jean-François Poulin; Bader Yassine-Diab; Bruno Guy; Brian J Ward; Nathalie Landry
Journal:  PLoS One       Date:  2019-06-05       Impact factor: 3.240

5.  Prime-pull vaccination with a plant-derived virus-like particle influenza vaccine elicits a broad immune response and protects aged mice from death and frailty after challenge.

Authors:  Breanna Hodgins; Stephane Pillet; Nathalie Landry; Brian J Ward
Journal:  Immun Ageing       Date:  2019-11-04       Impact factor: 6.400

Review 6.  Innovation in plant-based transient protein expression for infectious disease prevention and preparedness.

Authors:  Frank Sainsbury
Journal:  Curr Opin Biotechnol       Date:  2019-12-06       Impact factor: 9.740

7.  Efficacy of a plant-produced virus-like particle vaccine in chickens challenged with Influenza A H6N2 virus.

Authors:  Tanja Smith; Martha M O'Kennedy; Daniel B R Wandrag; Modupeore Adeyemi; Celia Abolnik
Journal:  Plant Biotechnol J       Date:  2019-08-22       Impact factor: 9.803

Review 8.  Non-viral COVID-19 vaccine delivery systems.

Authors:  Kyung Soo Park; Xiaoqi Sun; Marisa E Aikins; James J Moon
Journal:  Adv Drug Deliv Rev       Date:  2020-12-17       Impact factor: 17.873

Review 9.  Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development.

Authors:  Peter Pushko; Irina Tretyakova
Journal:  Viruses       Date:  2020-05-08       Impact factor: 5.048

10.  Progress in the development of virus-like particle vaccines against respiratory viruses.

Authors:  Fu-Shi Quan; Swarnendu Basak; Ki-Back Chu; Sung Soo Kim; Sang-Moo Kang
Journal:  Expert Rev Vaccines       Date:  2020-01-18       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.